Tennessee health care and public health leaders urge immediate action to protect state’s children from vaccine-preventable diseases
Measures proposed to address decline in adolescent vaccination associated with the COVID-19 pandemic
U.S. FDA APPROVES PREVNAR 20™, PFIZER’S PNEUMOCOCCAL 20-VALENT CONJUGATE VACCINE FOR ADULTS AGES 18 YEARS OR OLDER
Payment Terms Extension for Prevnar 13 and Trumenba. Please read FULL details in the letter from Pfizer.
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
A modern eLearning curriculum designed for any level of HCP on any type of device – smart phone, tablet, or computer. Personalized education based on the learner’s role and experience.
August is National Immunization Awareness Month (NIAM). This annual observance highlights the efforts of healthcare professionals to protect patients of all ages against vaccine-preventable diseases through on-time vaccination. It is critical to […]